The Nuclear Pharmacy Market Size is valued at USD 5.7 Bn in 2023 and is predicted to reach USD 12.8 Bn by the year 2031 at a 1091 % CAGR during the forecast period for 2024-2031.
Request for Free Sample Pages: https://www.insightaceanalytic.com/request-sample/1980
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global nuclear pharmacy market are:
- Technological advancement
- Growing innovative pharmaceuticals
- Increasing rates of cardiovascular disease and cancer
The following are the primary obstacles to the nuclear pharmacy market’s expansion:
- Standards for the safe administration of medications
- Concerns about data security
- Distressed healthcare workers
Future expansion opportunities for the global nuclear pharmacy market include:
- Increasing number of elderly people
- Rising need for diagnostics and image-guided procedures
- Accelerating research and development efforts
Market Analysis:
The rising incidence of chronic illnesses is mostly to blame for the market expansion. Additionally, technical developments that make diagnosing and treating malignant tumors possible with radiopharmaceuticals are driving market expansion. Additionally, the market participants concentrate on different approaches, such as introducing new products and acquisitions, which are anticipated to boost the nuclear medicine industry.
List of Prominent Players in the Nuclear Pharmacy Market:
- Jubilant Radiopharma (Jubilant Pharma Holdings Inc.)
- GE Healthcare
- Cardinal Health, Inc.
- ARTMS Inc.
- AnazaoHealth Corp.
- SOFIE
- Pacific Radiopharmacy, Ltd.
Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/1980
Recent Developments:
- In January 2024, Cardinal Health officially signed an agreement to pay $1.2 billion in cash to acquire Specialty Networks, a multi-specialty group purchasing and practice development company powered by technology. Specialty Networks create financial and clinical value for independent specialist physicians and partners through several specialty GPOs, such as United Rheumatology, Gastrologix, GastroGPO, UroGPO, and others.
- In Aug 2023, GE Healthcare announced the launch of Vscan Air, which will enhance point-of-care imaging capabilities in Nepal and enable access to distant places. The wireless portable ultrasound device enables whole-body scanning at the point of care in various care situations, thereby reducing costs and allowing medical practitioners to make decisions more rapidly and confidently.
- In Feb 2023, ARTMS Inc. was gratified to announce that Innovate BC has awarded it $300,000 as part of its Ignite initiative. The money will be supplemented with over $600,000 from additional sources to advance and validate the manufacture of zirconium-89 (Zr-89) for use in Positron Emission Tomography (PET) imaging scans of cancer patients eligible for immuno-oncology (IO) therapy.
Nuclear Pharmacy Market Dynamics:
Market Drivers: Technological Advancement
One of the important motivating elements is the great desire of many market participants to launch new items in this industry. Strong pipelines for diagnostic product development and the introduction of new products are the result of the growing demand for nuclear imaging. Additionally, many patients with chronic illnesses also encourage producers to introduce new goods into the market for radiopharmaceuticals. The elderly population is growing, cancer incidence is rising, and nuclear medicine is necessary for early disease diagnosis, all of which are factors driving market expansion.
Challenges: Standards for the Safe Administration of Medications
The pharmaceutical sector is subject to strict regulations governing its operations, including reporting and monitoring adverse drug reactions. Businesses struggle to comply with these intricate requirements in the allocation of resources, infrastructure, and expertise. The resources required to adhere to regulatory requirements could make adopting and implementing nuclear pharmacy systems and medication safety solutions challenging. One major obstacle to the expansion of this business is the difficulty of understanding and complying with the many different international regulations.
North America is Expected to Grow with the Highest CAGR During the Forecast Period
The North America nuclear pharmacy market is likely to register a significant revenue share and develop at a rapid CAGR in the near future. This is because of the increased use of cutting-edge and effective therapeutic radiopharmaceuticals throughout the area and the quick adoption of efficient nuclear imaging technologies. Beyond this, rising rates of chronic illnesses and other cancers are anticipated to drive this market’s expansion in North America throughout the projected year.
Get Specific Chapter/Information From The Report: https://www.insightaceanalytic.com/customisation/1980
Segmentation of Nuclear Pharmacy Market-
By Type-
- Diagnostic & Therapeutic Nuclear Medicine
By Application-
- Diagnostic
- Therapeutic
By Region-
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Details insights on this market: https://www.insightaceanalytic.com/report/nuclear-pharmacy-market/1980
Contact Us:
[email protected]
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/InsightaceA
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact Information:
Email: [email protected]
North America:
+1 551 226 6109
Asia:
+91 79 72967118
InsightAce
Tags:
BNN, Extended Distribution, Go Media, iCN Internal Distribution, IPS, Research Newswire, English